# Oklahoma Blood Institute – FDA Inspection, Jun 7, 2019

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/8799c476-b54f-4568-ae8a-d44019f898f3
Source feed: FDA_Inspections

> FDA inspection 1093994 of Oklahoma Blood Institute, June 07, 2019. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR parts 606, 610 and 630. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093994
- Company Name: Oklahoma Blood Institute
- Inspection Date: 2019-06-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 7

## Related Documents

- FDA Inspection 1231637 - 2024-08-20
- FDA Inspection 1023507 - 2017-06-20
- [FDA Inspection 945662 - 2015-08-20](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/c96c753d-4a80-4b39-ad43-26516fa74dd6)
- FDA Inspection 876145 - 2014-05-07
- FDA Inspection 810435 - 2012-10-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nimmy-mathews/9eac44d1-5e4c-493a-89c5-c7414a5a4037)
- [Issuing Officer](https://www.keypedia.com/people/william-f-lagud/c90c4bd6-bb56-4a60-a5f8-cbc648bb8dbe)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute/ab1c137b-3fd0-4fe5-b66a-7fabafad1868

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
